King’s support at Sandringham charity parkrun ‘means the world’ Charles cheered on participants on Saturday morning and chatted with local members of Move Against Cancer’s 5K Your Way group. Evening Standard · Feb 1
One in four school leavers have higher cancer risk because they skipped this vaccine A ‘concerning’ number of students are missing out on the crucial HPV vaccines, says health minister The Independent UK · Jan 29
Study finds no stomach cancer link to long-term acid reflux drugs Early research on the links was ‘hampered by several methodological limitations’ says researchers The Independent UK · Jan 21
Scotland first part of UK to approve ‘cutting edge’ treatment for stomach cancer The Scottish Medicines Consortium has approved zolbetuximab – to be used together with chemotherapy – to treat those with advanced stomach cancer. Evening Standard · Jan 19
United Airlines technician with Stage 4 cancer fired during chemotherapy session, lawsuit says Exclusive: ‘No one should have to choose between their health and their livelihood,’ a lawyer for 737 mechanic Hasan Syed told The Independent The Independent UK · Jan 14
Former Strictly Come Dancing star Punam Krishan reveals breast cancer diagnosis She said she was disclosing her diagnosis now because ‘carrying it quietly has been heavy’. Evening Standard · Jan 4
Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025 These three stocks started 2025 small, but graduated to mid-cap territory after +300% gains. See what caused their rise, and what analysts are forecasting. MarketBeat · Jan 3
Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder A Minnesota jury has awarded $65.5 million to a woman who claimed talcum products made by Johnson & Johnson exposed her to asbestos and contributed to her developing mesothelioma The Independent UK · Dec 20, 2025
Danielle Fishel is 'grateful' for her health and family after breast cancer treatment Boy Meets World star Danielle Fishel has revealed she's doing "great" after completing her cancer treatment. BANG Premier · Dec 17, 2025
King Charles 'deeply touched' by reaction to 'milestone' cancer message King Charles said he was deeply touched by the public and media reaction to his cancer recovery message, which boosted awareness of screening and led to a surge in people checking their eligibility. BANG Premier · Dec 13, 2025
'Early diagnosis quite simply is key' - King Charles's plea as he shares rare health update 'Your life - or the life of someone you love - may depend on it' Woman & Home · Dec 12, 2025
King Charles Will Reportedly Address 'Daunting And Frightening' Cancer Journey King Charles III will deliver a rare cancer address on Friday at 8pm, recorded at Clarence House, describing his diagnosis as 'daunting and frightening' while urging early screening. International Business Times UK · Dec 12, 2025
King Charles III to speak about his cancer treatment, recovery on TV show promoting early screening King Charles III will speak about his cancer diagnosis and recovery during a TV broadcast on Friday as the monarch continues to use his personal story to encourage others to get the early screening that can boost their chances of survival The Independent UK · Dec 12, 2025
BioNTech-Bristol Drug Shows Hope For Breast Cancer Patients With Few Options BioNTech SE (NASDAQ:BNTX) and Bristol Myers Squibb Co. (NYSE:BMY) on Tuesday shared the first interim data from a global randomized Phase 2 trial of pumitamig (BNT327/BMS986545) plus chemotherapy for locally advanced/metastatic triple-negative breast cancer (TNBC) irrespective of PD-L1 expression levels. Benzinga · Dec 9, 2025
Benzinga · Dec 9, 2025 Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial Exicure, Inc. (NASDAQ:XCUR) stock is trading higher on Tuesday. Its session volume was 13.62 million, compared with the average volume of 151.41 thousand, according to data from Benzinga Pro.
Benzinga · Dec 9, 2025 Tiny Biotech Terns Takes Aim At Novartis' Leukemia Blockbuster Terns Pharmaceuticals, Inc. (NASDAQ:TERN) on Monday presented updated and expanded data from the ongoing CARDINAL trial of TERN-701 in previously treated chronic myeloid leukemia (CML) patients at the American Society of Hematology Annual Meeting and Exposition.
Benzinga · Dec 8, 2025 Why Is Arcellx Stock Surging Today? Arcellx Inc. (NASDAQ:ACLX) shared new data on Saturday from its pivotal Phase 2 iMMagine-1 study of anitocabtagene autoleucel (anito-cel) for relapsed or refractory multiple myeloma (RRMM).
Benzinga · Dec 4, 2025 Pliant Cancer Drug Boosts Responses When Paired With Merck's Blockbuster Keytruda In Tough-To-Treat Tumors Pliant Therapeutics, Inc. (NASDAQ:PLRX) is capturing attention with promising trial results for its cancer therapy, despite a sharp stock decline.
Benzinga · Dec 2, 2025 Janux Therapeutics Stock Hits 52-Week Low After Trial Update Janux Therapeutics Inc. (NASDAQ:JANX) stock hit a 52-week low on Tuesday after the company released updated interim data for its JANX007 Phase 1 program for metastatic castration-resistant prostate cancer (mCRPC).
Benzinga · Nov 26, 2025 AstraZeneca Wins FDA Nod For Imfinzi Combination Regimen In Tough-To-Treat Stomach Cancers The U.S. Food and Drug Administration (FDA) on Tuesday approved AstraZeneca Plc's (NASDAQ:AZN) Imfinzi (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) for resectable, early-stage, and locally advanced gastric and gastroesophageal junction (GEJ) cancers.
International Business Times UK · Nov 25, 2025 Russia's Cancer Drug Approved in Vietnam; Pembroria Finds and Destroys Cancer Cells -- What We Know So Far Vietnam has approved the Russian cancer drug Pembroria, offering patients a new, cost‑effective treatment option. The move follows deeper health cooperation with Russia and comes as cancer cases in Vietnam nearly double over the past decade.
The Independent UK · Nov 24, 2025 Oregon family’s life turned upside down after mom and son receive cancer diagnoses on the same day: ‘It was pretty surreal’ The family hopes the little boy will be home in time to celebrate Christmas
We Got This Covered · Nov 24, 2025 ‘I’m most afraid of this’: Lawyer reveals the one common household product he refuses to touch, and it’s probably in your garage right now A scary household item warning
The Guardian - UK · Nov 20, 2025 Cancer Detectives: Finding the Cures review – this vaccine documentary is so inspirational it’ll make you weep The tale of Prof Sarah Blagden’s attempt to find a treatment that stops the disease is the rarest of things – TV that makes you dare to hope
Benzinga · Nov 17, 2025 Nuvalent Reports 31% Response Rate In Patients With Advanced Form Of Lung Cancer Nuvalent, Inc. (NASDAQ:NUVL) on Monday reported topline results from its ALKOVE-1 Phase 1/2 trial.